Hyaluronan serum concentrations are elevated in critically ill patients and associated with disease severity

Clinical Biochemistry

Volumn 45, Issue 1-2, 2012, Pages 82-87

  Yagmur, Eray ^a   Koch, Alexander ^b   Haumann, Michaela ^a   Kramann, Rafael ^b   Trautwein, Christian ^b   Tacke, Frank ^b  

^a Medical Care Center   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Biomarker; Critical illness; Hyaluronan; Intensive care medicine; Liver cirrhosis; Sepsis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CALCIUM; CHOLESTEROL; CHOLINESTERASE; CYSTATIN C; GLUCOSE; HYALURONIC ACID; LACTIC ACID; PROCALCITONIN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD LEVEL; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE SEVERITY; ENZYME BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HYALURONIC ACID BLOOD LEVEL; INFLAMMATION; INTENSIVE CARE UNIT; INTERNATIONAL NORMALIZED RATIO; KIDNEY DYSFUNCTION; LACTATE BLOOD LEVEL; LIVER CIRRHOSIS; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEPSIS; THROMBOCYTE COUNT;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CRITICAL ILLNESS; FEMALE; HOSPITAL MORTALITY; HUMANS; HYALURONIC ACID; INFLAMMATION; INTENSIVE CARE UNITS; LIVER; MALE; MIDDLE AGED; PROGNOSIS; SEPSIS;

EID: 84855333679     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.10.016     Document Type: Article

References (34)

1. Laurent T.C., Fraser J.R. Hyaluronan. FASEB J 1992, 6:2397-2404.
2. Jiang D., Liang J., Noble P.W. Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol 2007, 23:435-461.
3. Jiang D., Liang J., Noble P.W. Hyaluronan as an immune regulator in human diseases. Physiol Rev 2011, 91:221-264.
4. Elias J.A., Krol R.C., Freundlich B., Sampson P.M. Regulation of human lung fibroblast glycosaminoglycan production by recombinant interferons, tumor necrosis factor, and lymphotoxin. J Clin Invest 1988, 81:325-333.
5. McDonald B., McAvoy E.F., Lam F., et al. Interaction of CD44 and hyaluronan is the dominant mechanism for neutrophil sequestration in inflamed liver sinusoids. J Exp Med 2008, 205:915-927.
6. Muto J., Yamasaki K., Taylor K.R., Gallo R.L. Engagement of CD44 by hyaluronan suppresses TLR4 signaling and the septic response to LPS. Mol Immunol 2009, 47:449-456.
7. Eriksson S., Fraser J.R., Laurent T.C., Pertoft H., Smedsrod B. Endothelial cells are a site of uptake and degradation of hyaluronic acid in the liver. Exp Cell Res 1983, 144:223-228.
8. Martinez S.M., Crespo G., Navasa M., Forns X. Noninvasive assessment of liver fibrosis. Hepatology 2011, 53:325-335.
9. Veillon P., Gallois Y., Moal V., et al. Assessment of new hyaluronic acid assays and their impact on FibroMeter scores. Clin Chim Acta 2011, 412:347-352.
10. Adams L.A. Biomarkers of liver fibrosis. J Gastroenterol Hepatol 2011, 26:802-809.
11. Berg S., Brodin B., Hesselvik F., Laurent T.C., Maller R. Elevated levels of plasma hyaluronan in septicaemia. Scand J Clin Lab Invest 1988, 48:727-732.
12. Berg S., Jansson I., Hesselvik F.J., Laurent T.C., Lennquist S., Walther S. Hyaluronan: relationship to hemodynamics and survival in porcine injury and sepsis. Crit Care Med 1992, 20:1315-1321.
13. Teder P., Vandivier R.W., Jiang D., et al. Resolution of lung inflammation by CD44. Science 2002, 296:155-158.
14. Liu Y.Y., Lee C.H., Dedaj R., et al. High-molecular-weight hyaluronan - a possible new treatment for sepsis-induced lung injury: a preclinical study in mechanically ventilated rats. Crit Care 2008, 12:R102.
15. Koch A., Gressner O.A., Sanson E., Tacke F., Trautwein C. Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients. Crit Care 2009, 13:R95.
16. Koch A., Weiskirchen R., Sanson E., et al. Circulating retinol binding protein 4 in critically ill patients before specific treatment: prognostic impact and correlation with organ function, metabolism and inflammation. Crit Care 2010, 14:R179.
17. Koch A., Voigt S., Kruschinski C., et al. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients. Crit Care 2011, 15:R63.
18. Yagmur E., Tacke F., Weiss C., et al. Elevation of Nepsilon-(carboxymethyl)lysine-modified advanced glycation end products in chronic liver disease is an indicator of liver cirrhosis. Clin Biochem 2006, 39:39-45.
19. Koch A., Voigt S., Sanson E., et al. Prognostic value of circulating amino-terminal pro-C-type natriuretic peptide in critically ill patients. Crit Care 2011, 15:R45.
20. Koch A., Sanson E., Voigt S., Helm A., Trautwein C., Tacke F. Serum adiponectin upon admission to the intensive care unit may predict mortality in critically ill patients. J Crit Care 2011, 26:166-174.
21. Tamayo E., Montes M., Garcia-Medina G., Garcia-Arenzana J.M., Perez-Trallero E. Spread of a highly mucoid Streptococcus pyogenes emm3/ST15 clone. BMC Infect Dis 2010, 10:233.
22. Iida K., Seki M., Saito M., Kawamura Y., Kajiwara H., Yoshida S. Capsule of Streptococcus pyogenes is essential for delayed death of mice in a model of streptococcal toxic shock syndrome. Microbiol Immunol 2006, 50:127-130.
23. Vincent J.L., Moreno R. Clinical review: scoring systems in the critically ill. Crit Care 2010, 14:207.
24. Smedsrod B., Pertoft H., Eriksson S., Fraser J.R., Laurent T.C. Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells. Biochem J 1984, 223:617-626.
25. Zhou B., Weigel J.A., Fauss L., Weigel P.H. Identification of the hyaluronan receptor for endocytosis (HARE). J Biol Chem 2000, 275:37733-37741.
26. Pecoits-Filho R., Heimburger O., Barany P., et al. Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis 2003, 41:1212-1218.
27. Ohlson M., Sorensson J., Lindstrom K., Blom A.M., Fries E., Haraldsson B. Effects of filtration rate on the glomerular barrier and clearance of four differently shaped molecules. Am J Physiol Renal Physiol 2001, 281:F103-F113.
28. Pierrakos C., Vincent J.L. Sepsis biomarkers: a review. Crit Care 2010, 14:R15.
29. Do Y., Nagarkatti P.S., Nagarkatti M. Role of CD44 and hyaluronic acid (HA) in activation of alloreactive and antigen-specific T cells by bone marrow-derived dendritic cells. J Immunother 2004, 27:1-12.
30. Khan A.I., Kerfoot S.M., Heit B., et al. Role of CD44 and hyaluronan in neutrophil recruitment. J Immunol 2004, 173:7594-7601.
31. Rouschop K.M., Roelofs J.J., Claessen N., et al. Protection against renal ischemia reperfusion injury by CD44 disruption. J Am Soc Nephrol 2005, 16:2034-2043.
32. Takazoe K., Tesch G.H., Hill P.A., et al. CD44-mediated neutrophil apoptosis in the rat. Kidney Int 2000, 58:1920-1930.
33. Singleton P.A., Mirzapoiazova T., Guo Y., et al. High-molecular-weight hyaluronan is a novel inhibitor of pulmonary vascular leakiness. Am J Physiol Lung Cell Mol Physiol 2010, 299:L639-L651.
34. Termeer C., Sleeman J.P., Simon J.C. Hyaluronan - magic glue for the regulation of the immune response?. Trends Immunol 2003, 24:112-114.